Part Details | CEPHRADINE CAPSULES
6505-01-023-8714
Alternate Parts: NDC00555055102, NDC00555-0551-02, NDC00332315509, NDC00332-3155-09, NDC00003011450, NDC00003-0114-50, NDC00003011450, NDC00003-0114-50, NDC00182125401, NDC00182-1254-01, NDC00781253401, NDC00781-2534-01, NDC00003011450, NDC00003-0114-50, VELOSEF 500 CAPSULES, 6505-01-023-8714, 01-023-8714, 6505010238714, 010238714
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | JUN 27, 1976 | 01-023-8714 | 33970 ( CEPHRADINE CAPSULES ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-023-8714
Part Number | Cage Code | Manufacturer |
---|---|---|
NDC00555-0551-02 | 56490 | BARR LABORATORIES, INC. |
NDC00332-3155-09 | 60749 | BIOCRAFT LABORATORIES INCCORPORATE HQ |
NDC00003-0114-50 | 71115 | BRISTOL-MYERS CO |
NDC00003-0114-50 | 1M8G6 | BRISTOL-MYERS SQUIBB COMPANYDBA BRISTOL-MYERS SQUIBB |
NDC00182-1254-01 | 63488 | GOLDLINE LABORATORIES INC.DBA GOLDLINE LABORATORIES |
NDC00781-2534-01 | 0THL4 | SANDOZ INC. |
NDC00003-0114-50 | 78473 | SQUIBB E R AND SONS INCWORLD HQ |
VELOSEF 500 CAPSULES | 78473 | SQUIBB E R AND SONS INCWORLD HQ |
Technical Data | NSN 6505-01-023-8714
Characteristic | Specifications |
---|---|
CAPSULE TYPE | |
CAPSULE CONTENT FORM | |
ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB500.000 MILLIGRAMS CEPHRADINE |
PRIMARY CONTAINER TYPE | BOTTLE |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
PART NAME ASSIGNED BY CONTROLLING AGENCY | CEPHRADINE CAPSULES USP 500 MG 100S BT |